SmartPICC-1 Feasibility Study Technical Feasibility Study (NCT05548192) | Clinical Trial Compass
CompletedNot Applicable
SmartPICC-1 Feasibility Study Technical Feasibility Study
United States42 participantsStarted 2021-04-01
Plain-language summary
The primary objective of this study is to evaluate the safety and technical feasibility of the Piccolo Medical SmartPICC System, indicated for guidance and positioning of commercially available central venous catheters, for PICC placement in adults.
Who can participate
Age range22 Years – 85 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subject has provided written informed consent, including authorization to release health information
* Subject between 22-85 years of age at the time of consent
* Subject is scheduled for PICC placement
* Subject understands and is able and willing to comply with the study requirements
* Subject has provided a negative pregnancy test (if subject is a woman of childbearing potential (WOCBP))
Exclusion Criteria:
* Contraindicated for PICC
* Subject is enrolled in another clinical study where the safety profile is not yet established or may otherwise confound the SmartPICC-1 Study results
* Subject is deemed ineligible for the study in the opinion of the investigator, physician, and/or PICC nurse
* Subject has single ventricle anatomy
* Subject has a BMI that, in the opinion of the investigator, physician, and/or PICC nurse, would interfere with successful PICC placement
* Subjects with known stenosis of the upper arm and right-side veins that may prevent successful PICC placement
* Subject has mechanical circulatory support device (e.g. ECMO, VAD)
* Subject is pregnant
* Subject has or is suspected to have COVID-19